Same dudes on here calling the elusive 'bounce'. Same guys...

Same dudes on here calling the elusive 'bounce'. Same guys calling it since $2.50. Same dudes saying way oversold. This thread is so predictable.

Every month they spend. Every month that cash balance capitulates. Very little revenue. Until revenue rises substantially, I'd stay clear of this. Unless you know the Product inside out and it's advantages over the competition then you'd be a massive risk taker buying. Fundamentals don't justify a buy. The cash backing argument is weak with this stock due to the high cash outflows on operational expenditure.